Skip to content
Wenlo
Sign in
← Markets

Colgate-Palmolive Co.

Panagiotis Tsourapas (COO, CD, EMEA, APac, Skin) sells CL shares

4CLFiled Nov 6, 2026, 4:05 PM ET· Period Nov 4, 2026

AI-generated summary

COO, CD, EMEA, APac, Skin Panagiotis Tsourapas exercised stock options for 19,938 shares for $1,523,462.58 and sold 19,938 shares for $1,968,708.03. Following these transactions, Panagiotis Tsourapas directly held 9,111 shares of common stock.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Panagiotis Tsourapas · COO, CD, EMEA, APac, Skin
DateTransactionSharesPriceValueHeld afterOwnership
Nov 4, 2026M · exercise or conversion of a derivativeFootnotes F1+19,938$76.41$1,523,462.5829,049Direct
Nov 4, 2026S · open-market saleFootnotes F2, F3−19,938$98.74$1,968,708.039,111Direct
Nov 4, 2026M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F5−19,938$0.00$0.000Direct
Footnotes
  1. F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
  2. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
  3. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $98.585 to $98.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4 This amount includes 2,336 shares that were previously reported as directly beneficially owned.
  5. F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

More CL filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.